Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Tamoxifen citrate

EU orphan designation number: EU/3/17/1944   
Active ingredient: Tamoxifen citrate
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: Duchenne UK
11 Bedford Road, London W4 1JD, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
10/11/2017 Orphan designation EMA/OD/133/17 (2017)7566 of 8/11/2017